BPC-157 | Side Effects and Complications When comparing the safety and side effects of TB-500 vs BPC-157, it is important to note that only TB-500 has been extensively clinically studied
This can lead to aberrations in various cellular signaling pathways, which can result in cellular toxicity and death from chemotherapy or radiation therapy (9, 10)
Taso CJ, Lin HS, Lin WL, Chen SM, Huang WT, Chen SW
Expert Rev Dermatol
My Protocol: 0.3 mg BPC-157 injected subcutaneously about 2 inches from my lateral epicondyle, once each morning, for 6 weeks straight
Among these emerging compounds, Cagrilintide stands out for its promising synergy when paired with agents like semaglutide and tirzepatide